Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
F. Michael (Mike) Ball.
Hospira Inc. has named F. Michael Ball, president of Botox maker Allergan Inc., as its next top executive, succeeding the only CEO the Lake Forest-based maker of generic injectable drugs has had since it was spun off from Abbott Laboratories.
Ball, 55, will Hospira become chief executive March 28, replacing Christopher Begley, who will retire after nearly seven years in the top job, the company announced late Monday. Hospira was spun off as a public company from North Chicago-based Abbott Laboratories in 2004. Get the full story »
Women who have breast implants may be at greater risk for a rare but serious cancer, U.S. health regulators warned Wednesday.
The Food and Drug Administration said it is looking at a possible link between silicone and saline breast implants and a type of anaplastic large cell lymphoma, which targets the immune system. The agency said overall it still believes implants are safe. Get the full story »
